125 related articles for article (PubMed ID: 19335783)
1. Cytokines and liver injury in chronic HCV genotype 4 infection.
Zekry A
J Gastroenterol Hepatol; 2009 Mar; 24(3):332-5. PubMed ID: 19335783
[No Abstract] [Full Text] [Related]
2. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
3. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
4. HCV-related hepatocellular carcinoma: From chronic inflammation to cancer.
Castello G; Scala S; Palmieri G; Curley SA; Izzo F
Clin Immunol; 2010 Mar; 134(3):237-50. PubMed ID: 19910258
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
Yamashita T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2011 Jun; 26(6):960-4. PubMed ID: 21443660
[TBL] [Abstract][Full Text] [Related]
6. [HCV-related hepatocellular carcinoma].
Otsuka M; Kato N; Yoshida H; Yoshida H; Shiratori Y; Omata M
Uirusu; 2002 Dec; 52(2):295-300. PubMed ID: 12685322
[No Abstract] [Full Text] [Related]
7. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation.
Golden-Mason L
Liver Transpl; 2009 Apr; 15(4):357-9. PubMed ID: 19326413
[No Abstract] [Full Text] [Related]
9. Apoptosis in hepatitis C virus infection.
Bantel H; Schulze-Osthoff K
Cell Death Differ; 2003 Jan; 10 Suppl 1():S48-58. PubMed ID: 12655346
[TBL] [Abstract][Full Text] [Related]
10. Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus.
Steuerwald NM; Parsons JC; Bennett K; Bates TC; Bonkovsky HL
Liver Int; 2010 Nov; 30(10):1490-504. PubMed ID: 20825557
[TBL] [Abstract][Full Text] [Related]
11. Implication of protein kinase R gene quantification in hepatitis C virus genotype 4 induced hepatocarcinogenesis.
Mohamed AA; Nada OH; El Desouky MA
Diagn Pathol; 2012 Aug; 7():103. PubMed ID: 22894766
[TBL] [Abstract][Full Text] [Related]
12. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma.
Farinati F; Cardin R; Bortolami M; Burra P; Russo FP; Rugge M; Guido M; Sergio A; Naccarato R
J Viral Hepat; 2007 Dec; 14(12):821-9. PubMed ID: 18070284
[TBL] [Abstract][Full Text] [Related]
14. Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.
Wong MT; Chen SS
Cell Mol Immunol; 2016 Jan; 13(1):11-35. PubMed ID: 25544499
[TBL] [Abstract][Full Text] [Related]
15. [HCV genome in type C hepatocellular carcinoma].
Yamada G
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):777-81. PubMed ID: 7563874
[No Abstract] [Full Text] [Related]
16. HBV + HCV = HCC?
Cramp ME
Gut; 1999 Aug; 45(2):168-9. PubMed ID: 10403725
[No Abstract] [Full Text] [Related]
17. Hepatitis C virus genotype 1b, cirrhosis, and risk of hepatocellular carcinoma.
Sangiovanni A; Iavarone M
Hepatology; 2008 Jan; 47(1):357; author reply 357-8. PubMed ID: 18161732
[No Abstract] [Full Text] [Related]
18. A lymphotoxin-driven pathway to hepatocellular carcinoma.
Haybaeck J; Zeller N; Wolf MJ; Weber A; Wagner U; Kurrer MO; Bremer J; Iezzi G; Graf R; Clavien PA; Thimme R; Blum H; Nedospasov SA; Zatloukal K; Ramzan M; Ciesek S; Pietschmann T; Marche PN; Karin M; Kopf M; Browning JL; Aguzzi A; Heikenwalder M
Cancer Cell; 2009 Oct; 16(4):295-308. PubMed ID: 19800575
[TBL] [Abstract][Full Text] [Related]
19. Lymphotoxins: new targets for hepatocellular carcinoma.
Villanueva A; Savic R; Llovet JM
Cancer Cell; 2009 Oct; 16(4):272-3. PubMed ID: 19800570
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon.
Lukasiak S; Schiller C; Oehlschlaeger P; Schmidtke G; Krause P; Legler DF; Autschbach F; Schirmacher P; Breuhahn K; Groettrup M
Oncogene; 2008 Oct; 27(46):6068-74. PubMed ID: 18574467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
